NIH-funded research Career grant

Understanding brain-metastasis CD8+ T cells and how they fight cancer in the brain

Official title: Characterization of brain metastasis-specific CD8+ T cells

Funded at Emory University · NIH-11391292 · Data updated 2026-11-12

This grant studies how a special type of immune cells, CD8+ T cells, behaves inside brain tumors to find ways to improve immune-based cancer therapies.

More Metastasis research and trials

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionEmory University
NIH-funded
Lab location1 site (Atlanta, United States)
Project startAugust 9, 2022
Project endJuly 31, 2027
Funding year2026
Award (this year)$132,549
NIH project number5K08AI166837-05
Project IDNIH-11391292 on NIH RePORTER

Who could benefit from this research

Could help

Patients with brain metastases or those contributing brain tumor tissue samples may be eligible for related studies or future trials.

Less likely to help

Patients without brain metastases or without access to brain tissue samples may not directly benefit from this specific project.

What this research studies

CD8+ T cells can kill cancer cells, but they can become “exhausted” and less effective, especially in the brain. The project aims to map the different CD8+ T cell types present in brain metastases and understand their gene activity. By using human brain tumor samples and mouse models, the research will explore how these T cells respond to immune therapies and identify targets to boost their tumor-killing power in the brain. This work could inform the development of more effective treatments for patients with brain metastases.

Why it matters

Potential benefit: If successful, the findings could lead to better immunotherapies that work in the brain and improve survival for patients with brain metastases.

How similar studies have gone: Previous work has shown distinct CD8+ T cell populations in brain tumors and some responses to immunotherapy, but brain-specific transcriptional profiles are still being defined.

Where this research is happening

  • Emory University
    Atlanta, United States
    Active

Researchers

  • Principal investigator: Sudmeier, Lisa — Emory University
  • Study coordinator: Sudmeier, Lisa

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.